Northern Trust’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,600
| Closed | -$24.6K | – | 4423 |
|
|
2025
Q1 | $24.6K | Hold |
2,600
| – | – | ﹤0.01% | 4318 |
|
|
2024
Q4 | $23.3K | Buy |
2,600
+564
| +28% | +$5.06K | ﹤0.01% | 4362 |
|
|
2024
Q3 | $131K | Hold |
2,036
| – | – | ﹤0.01% | 3992 |
|
|
2024
Q2 | $153K | Buy |
2,036
+291
| +17% | +$21.8K | ﹤0.01% | 3943 |
|
|
2024
Q1 | $208K | Buy |
1,745
+1,322
| +313% | +$158K | ﹤0.01% | 3884 |
|
|
2023
Q4 | $35.1K | Buy |
+423
| New | +$35.1K | ﹤0.01% | 4295 |
|
|
2022
Q3 | – | Sell |
-318
| Closed | -$39K | – | 4722 |
|
|
2022
Q2 | $39K | Hold |
318
| – | – | ﹤0.01% | 4474 |
|
|
2022
Q1 | $66K | Hold |
318
| – | – | ﹤0.01% | 4465 |
|
|
2021
Q4 | $63K | Hold |
318
| – | – | ﹤0.01% | 4546 |
|
|
2021
Q3 | $88K | Hold |
318
| – | – | ﹤0.01% | 4433 |
|
|
2021
Q2 | $114K | Hold |
318
| – | – | ﹤0.01% | 4332 |
|
|
2021
Q1 | $154K | Buy |
318
+170
| +115% | +$82.3K | ﹤0.01% | 4178 |
|
|
2020
Q4 | $92K | Buy |
148
+64
| +76% | +$39.8K | ﹤0.01% | 4131 |
|
|
2020
Q3 | $31K | Buy |
+84
| New | +$31K | ﹤0.01% | 4154 |
|
|
2018
Q3 | – | Sell |
-10
| Closed | -$18K | – | 4314 |
|
|
2018
Q2 | $18K | Hold |
10
| – | – | ﹤0.01% | 4222 |
|
|
2018
Q1 | $33K | Buy |
10
+3
| +43% | +$9.9K | ﹤0.01% | 4123 |
|
|
2017
Q4 | $27K | Buy |
7
+2
| +40% | +$7.71K | ﹤0.01% | 4131 |
|
|
2017
Q3 | $28K | Hold |
5
| – | – | ﹤0.01% | 4121 |
|
|
2017
Q2 | $27K | Hold |
5
| – | – | ﹤0.01% | 4152 |
|
|
2017
Q1 | $37K | Buy |
+5
| New | +$37K | ﹤0.01% | 4087 |
|